A Novel Nomogram Combining Mucus Barrier Index for Predicting Treatment Failures in Ulcerative Colitis
DOI: https://doi.org/10.2147/JIR.S410057
IF: 4.5
2023-05-01
Journal of Inflammation Research
Abstract:Ying Wang, 1, &ast Xuanzhi Huang, 1, &ast Gaoshi Zhou, 1 Jing Han, 1 Zhuo Xie, 1 Mudan Zhang, 1 Xiaoling Li, 1 Qi-rui Wu, 1 Li Li, 1 Ziyin Ye, 2 Minhu Chen, 1 Yun Qiu, 1 Shenghong Zhang 1 1 Department of Gastroenterology, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong Province, People's Republic of China; 2 Department of Pathology, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong Province, People's Republic of China &astThese authors contributed equally to this work Correspondence: Shenghong Zhang; Yun Qiu, Department of Gastroenterology, First Affiliated Hospital of Sun Yat-sen University, 58 Zhongshan Road 2, Guangzhou Province, 510080, People's Republic of China, Tel/Fax +86-20-87332916, Email ; Background: Treatment failures (TFs) generally exist in the course of ulcerative colitis (UC), while early reliable predictors of TFs are still lacking. We aimed to generate nomograms for the prediction of TFs. Methods: In this retrospective case–control study, the endpoint was the occurrence of TFs, which included medically associated treatment failures and surgery-associated treatment failures (colectomy). Clinical features and mucus integrity evident by goblet cells (GCs) number, expression levels of MUC2 and SLC26A3 were enrolled in the univariate analysis. Nomogram performance was evaluated by discrimination and calibration. Results: We identified 256 UC patients at our center from January 2010 to June 2022. Fourteen variables for TFs and 9 for colectomy were identified by univariate analysis. Five baseline indices were incorporated into the nomogram for the prediction of TFs: area of GCs, age at diagnosis, disease duration, hemoglobin, and Mayo score. The model was presented with decent discrimination ( C index of 0.822) and well calibration. In addition, the colectomy predictive nomogram was built using MUC2 intensity, age at onset, and Mayo score with a good discrimination ( C index of 0.92). Conclusion: Nomograms based on comprehensive factors including mucus barrier function were developed to predict TFs in UC patients with great discrimination, which may serve as practical tools aiming to identify high-risk subgroups warrant timely intervention. Keywords: ulcerative colitis, treatment failure, nomogram, mucus barrier Ulcerative colitis (UC), a common subtype of inflammatory bowel disease (IBD), is presented with high morbidity universally. 1,2 Given its frequent relapse and incurable features, UC has evolved as a global burden. 3,4 Even though it is easier to get control than other IBD patients, a few patients still experience unbeneficial outcomes, such as loss of control under monotherapy or surgical treatment. 5,6 Even the loss of response to biological intervention by biologic would occur in the unfortunate. 7,8 Constant transition of therapy is common because of drug resistance or intolerance. 9,10 Surgery is an unavoidable method for patients presented no response to medications or with identified colorectal neoplasm. 5,6 Colectomy, as a paradigm surgery for UC, severely affects the patients' quality of life. 3 No general validated definition has been identified for treatment failures (TFs) in UC patients. Few studies simply defined TFs with monotherapy as the absence of clinical response. 11–13 These patients exhibit a more progressive disease course for advanced therapy. Hence, a predictive model to identify patients that warrant timely intervention is necessary. Currently, few studies have reported on developing risk prediction models for UC-related TFs, which mostly focused on monotherapy efficacy or surgery risk individually, and mainly included only routine clinical factors. 14,15 The mucus barrier 16,17 plays an essential role in the pathogenesis of UC, and its impairment is proven to be an early event. 18 Single-cell RNA sequencing revealed a changed profile of colonic goblets in UC patients. 17 Goblet cells (GCs) depletion, a typical histological variation in UC, was an independent risk factor for clinical relapse, especially in patients with endoscopic remission (Mayo endoscopic score [MES] of 0). 19,20 The dextran sulfate sodium model with MUC2 deficiency, a key component of colonic mucus, was accompanied by severe colitis, 21 and the total amount of MUC2 varied with the disease activity of UC patients. SLC26A3, an ion channel for chloride ion transport in the epithelium, was rarely discovered as an indicato -Abstract Truncated-
immunology